MedVector

Telemedicine for Clinical Trials

Security Type: Common Stock
Min Investment: $496
Location: El Segundo, CA
Offering Date: October 20, 2020
Expected Close Date: April 22, 2021
Target Raise: $10.00K-$1.07M
Deal Notes: Price per Share: $1.45
Valuation: $10,000,000

Company Description

MedVector is an industry-first telemedicine platform that greatly accelerates clinical trials. By connecting subjects from anywhere in the world to existing clinical trial sites, MedVector has proven to exponentially increase clinical trial participation and dramatically accelerate FDA approval. Our service generates revenue for doctors and hospitals, reduces costs to clinical trial sponsors, and brings life-changing, advanced medicine to the market more quickly.

Key Deal Facts

The Clinical Trials Market is currently worth ~$47 billion, with a predicted value of $104 billion based on our extensive research.
We have one of the world's largest clinical trial networks, obtaining access to 7 hospitals consisting of hundreds of thousands of patients per year.
During clinical trials for Novartis, our progress greatly excelled against traditional patient recruitment services. In just 7 weeks we were able to do what often take years.

Management Team / Advisory Board Bios

Scott Stout
CO-FOUNDER / CEO
Scott Stout is a Co-Founder and the CEO of MedVector. Prior to founding MedVector, Scott was an investment specialist at Morgan Stanley and an options strategist with D&S Investments. He has helped numerous startups with their investor models, valuations, and go-to-market strategies. His investor acumen, financial expertise and entrepreneurial spirt, make him an excellent leader for MedVector’s mission.

Dr. Dennis J. Patterson
CO-FOUNDER / SVP MEDICAL AFFAIRS
Dr. Patterson is a senior hospital administrator turned entrepreneur (7 startups, 1 major exit, Wellspring Partners). He has been instrumental in devising and implementing healthcare programs that dramatically improve performance in some of the nation’s top hospitals and health systems. Dr. Patterson has held pivotal roles in senior management at Wellspring Partners, HealthcareNet, FHP Consulting, Ernst & Young, Westcare Consultants, Shaughnessy, Vancouver General, Misercordia, and Oak Forest Hospitals. He lectures internationally on healthcare issues and is the author of numerous books and publications including Indexing Managed Care (McGraw-Hill).

Deal Notes

Price per Share: $1.45

Amount Raised : $904,166

Reveal the Score by Voting

＿

Additional ratings from other users are needed to determine a viable CrowdScore for this deal.

The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.

ⓘ

The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.

Business Idea

ⓘ

The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.

Business Traction

ⓘ

The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.

Management Team

ⓘ

The value of the company compared to similar companies raising money from investors.

Valuation

Have you done enough research to provide a rating? This is important for your fellow investors.

We only allow one revision to each rating category. Be sure about any changes.

Security Description

Common stock is a security that represents ownership in a corporation.

Research Reports

No reports have been submitted

Become a Reporter

Read Our Research Disclaimer

0 Comments

To claim your deal, you must have access to @ email

Contact support@crowdlustro.com if you need assistance.